150 related articles for article (PubMed ID: 25237468)
21. Stimulation of cytokine release and adhesion molecule expression by products of Viridans streptococci.
Hanage WP; Cohen J
J Infect Dis; 2002 Feb; 185(3):357-67. PubMed ID: 11807718
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer.
Shelburne SA; Chaftari AM; Jamal M; Al Wohoush I; Jiang Y; Abughazaleh S; Cairo J; Raad S; Debiane L; Raad I
Am J Infect Control; 2014 Oct; 42(10):1127-9. PubMed ID: 25278410
[TBL] [Abstract][Full Text] [Related]
23. Complete Genome Sequence of Streptococcus mitis Strain SVGS_061 Isolated from a Neutropenic Patient with Viridans Group Streptococcal Shock Syndrome.
Petrosyan V; Holder M; Ajami NJ; Petrosino JF; Sahasrabhojane P; Thompson EJ; Kalia A; Shelburne SA
Genome Announc; 2016 Apr; 4(2):. PubMed ID: 27056234
[TBL] [Abstract][Full Text] [Related]
24. Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.
Salavert M; Gómez L; Rodriguez-Carballeira M; Xercavins M; Freixas N; Garau J
Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):365-71. PubMed ID: 8793393
[TBL] [Abstract][Full Text] [Related]
25. Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.
Sahasrabhojane P; Galloway-Peña J; Velazquez L; Saldaña M; Horstmann N; Tarrand J; Shelburne SA
Int J Antimicrob Agents; 2014 Jun; 43(6):558-62. PubMed ID: 24721231
[TBL] [Abstract][Full Text] [Related]
26. Viridans-group streptococcal infections in immunocompromised hosts.
Shenep JL
Int J Antimicrob Agents; 2000 Mar; 14(2):129-35. PubMed ID: 10720803
[TBL] [Abstract][Full Text] [Related]
27. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.
Kern W; Kurrle E; Schmeiser T
Infection; 1990; 18(3):138-45. PubMed ID: 2365465
[TBL] [Abstract][Full Text] [Related]
28. Streptococcus mitis strains causing severe clinical disease in cancer patients.
Shelburne SA; Sahasrabhojane P; Saldana M; Yao H; Su X; Horstmann N; Thompson E; Flores AR
Emerg Infect Dis; 2014 May; 20(5):762-71. PubMed ID: 24750901
[TBL] [Abstract][Full Text] [Related]
29. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors of septic shock and mortality in neutropenic patients.
Ramzi J; Mohamed Z; Yosr B; Karima K; Raihane B; Lamia A; Hela BA; Zaher B; Balkis M
Hematology; 2007 Dec; 12(6):543-8. PubMed ID: 17852435
[TBL] [Abstract][Full Text] [Related]
31. Effect of Periodontal Therapy With Amoxicillin-Metronidazole on Pharyngeal Carriage of Penicillin- and Erythromycin-Resistant Viridans Streptococci.
Mombelli A; Cionca N; Almaghlouth A; Cherkaoui A; Schrenzel J; Giannopoulou C
J Periodontol; 2016 May; 87(5):539-47. PubMed ID: 26654350
[TBL] [Abstract][Full Text] [Related]
32. Value of matrix-assisted laser desorption ionization-time of flight for routine identification of viridans group streptococci causing bloodstream infections.
López Roa P; Sánchez Carrillo C; Marín M; Romero F; Cercenado E; Bouza E
Clin Microbiol Infect; 2013 May; 19(5):438-44. PubMed ID: 22510157
[TBL] [Abstract][Full Text] [Related]
33. It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations.
Doern CD; Burnham CA
J Clin Microbiol; 2010 Nov; 48(11):3829-35. PubMed ID: 20810781
[TBL] [Abstract][Full Text] [Related]
34. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
35. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
Razonable RR; Litzow MR; Khaliq Y; Piper KE; Rouse MS; Patel R
Clin Infect Dis; 2002 Jun; 34(11):1469-74. PubMed ID: 12015693
[TBL] [Abstract][Full Text] [Related]
36. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
37. GyrB polymorphisms accurately assign invasive viridans group streptococcal species.
Galloway-Peña J; Sahasrabhojane P; Tarrand J; Han XY; Shelburne SA
J Clin Microbiol; 2014 Aug; 52(8):2905-12. PubMed ID: 24899021
[TBL] [Abstract][Full Text] [Related]
38. Viridans streptococcal isolates from patients with septic shock induce tumor necrosis factor-alpha production by murine macrophages.
Orlicek SL; Branum KC; English BK; McCordic R; Shenep JL; Patrick CC
J Lab Clin Med; 1997 Nov; 130(5):515-9. PubMed ID: 9390639
[TBL] [Abstract][Full Text] [Related]
39. Bacteremia caused by viridans streptococci in 71 children.
Gaudreau C; Delage G; Rousseau D; Cantor ED
Can Med Assoc J; 1981 Dec; 125(11):1246-9. PubMed ID: 7332884
[TBL] [Abstract][Full Text] [Related]
40. Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis.
Ercibengoa M; Goenaga MA; Ardanuy C; Grau I; García-de-la-Maria C; Almela M; Miro JM; Navas E; Fariñas MC; de Alegría CR; de la Torre J; Fernández F; Marín M; Muñoz P; Orden B; Oteo JA; García-Álvarez L; de Alarcón A; Jiménez JAL; Marimón JM
BMC Infect Dis; 2019 Mar; 19(1):291. PubMed ID: 30922322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
